QEYOSA

Serial Number 97715316
732

Registration Progress

Application Filed
Dec 13, 2022
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Dec 19, 2025 158 days

Trademark Image

QEYOSA

Basic Information

Serial Number
97715316
Filing Date
December 13, 2022
Published for Opposition
October 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Jun 9, 2025
Application
Pending
Classes
005

Rights Holder

Apnimed, Inc.

03
Address
39 John F. Kennedy Street, 4th Floor
Cambridge, MA 02138

Ownership History

Apnimed, Inc.

Original Applicant
03
Cambridge, MA

Apnimed, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sean McConnell

USPTO Deadlines

Next Deadline
158 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 19, 2025
Extension Available
Until December 19, 2024

Application History

19 events
Date Code Type Description
Jun 9, 2025 EX3G S SOU EXTENSION 3 GRANTED
Jun 9, 2025 EXT3 S SOU EXTENSION 3 FILED
Jun 9, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 16, 2024 EX2G S SOU EXTENSION 2 GRANTED
Oct 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2024 EXT2 S SOU EXTENSION 2 FILED
Oct 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2024 EX1G S SOU EXTENSION 1 GRANTED
Jan 19, 2024 EXT1 S SOU EXTENSION 1 FILED
Jan 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2023 DOCK D ASSIGNED TO EXAMINER
Dec 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of obstructive sleep apnea, symptomatic snoring, and sleep disorders

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...